Davis Polk advised J.P. Morgan Securities LLC as sole underwriter in the SEC-registered offering by Insulet Corporation of $125 million aggregate principal amount of its 3.75% convertible senior notes due 2016, plus an $18.75 million over-allotment option, which has been exercised by the underwriter. Davis Polk also advised J.P. Morgan Securities LLC as representative of the several underwriters in the SEC-registered offering by Insulet’s selling stockholders of 1,153,420 shares of Insulet common stock. The selling stockholders received shares of Insulet in connection with Insulet’s recent acquisition of Neighborhood Diabetes, Inc., a medical equipment distributor specializing in direct to consumer sales of diabetes supplies. The common stock is listed on the Nasdaq Global Market under the symbol “PODD.”

In a decisive win for eBay Inc., Weil, Gotshal & Manges obtained dismissal of the final claims in a breach of contract action that had been pending in California state court for three years. The court granted dismissal of the action, Ruins & Genesta v. eBay, Case No. 30-2009 00124542, Superior Court of the State of California for the County of Orange, on June 21, 2011.

Last week, Goodwin Procter attorneys helped secure a victory for long-time client Teva Pharmaceuticals and for manufacturers of generic drugs generally, when the U.S. Supreme Court ruled in PLIVA v. Mensing.  Goodwin’s team was instrumental in drafting the certiorari and merits briefs before the Court.

Hogan Lovells advised S1 Corporation on its combination with Fundtech Ltd. in a stock-for-stock merger deal valued at approximately $700 million.